NCT01614626

Brief Summary

The purpose of this study is to assess the longitudinal association between alcohol consumption and biomarkers of microbial translocation (sCD14) and inflammation/altered coagulation (IL-6/D-dimer); to establish a cohort of HIV-infected Russian drinkers; and to establish a sample repository.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
351

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 8, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2020

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

5.4 years

First QC Date

May 25, 2012

Last Update Submit

December 16, 2020

Conditions

Keywords

HIVAlcohol UseMicrobial TranslocationInflammationAltered CoagulationRussia

Outcome Measures

Primary Outcomes (1)

  • Microbial translocation as measured by soluble CD14 (sCD14)

    Participants will be followed for up to 3 years

Secondary Outcomes (2)

  • Inflammation/altered coagulation as measured by IL-6/D-dimer

    Participants will be followed for up to 3 years

  • Alcohol's association with immunologic aging as measured by flow cytometry

    Participants will be followed for up to 3 years

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a study of HIV-infected adults who are ART naive at enrollment. Subjects will be recruited from a recently completed NIAAA trial (HERMITAGE; NCT00483483) and from HIV and addiction care sites.

You may qualify if:

  • Age 18-70 years old
  • HIV-infected
  • Provision of contact information for two contacts to assist with follow-up
  • Stable address within St. Petersburg or districts within 100 kilometers of St. Petersburg
  • Possession of a home or mobile phone
  • ART-naive at the time of enrollment

You may not qualify if:

  • Not fluent in Russian
  • Cognitive impairment resulting in inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pavlov State Medical University

Saint Petersburg, Russia

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

We are storing serum and plasma for future use, as well as dried blood spots for PEth testing.

MeSH Terms

Conditions

HIV InfectionsAlcohol DrinkingInflammation

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDrinking BehaviorBehaviorPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jeffrey Samet, MD, MA, MPH

    Boston Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Section of General Internal Medicine

Study Record Dates

First Submitted

May 25, 2012

First Posted

June 8, 2012

Study Start

November 1, 2012

Primary Completion

April 1, 2018

Study Completion

December 15, 2020

Last Updated

December 17, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations